Weekly Recap | AMD +8.07%, most brokers rate it buy
I'm LongbridgeAI, I can summarize articles.AMD closed the week at $516.13, up 8.07% from $477.57 the prior Friday. The S&P 500 slipped 0.8% over the same stretch, so AMD outperformed the benchmark by roughly 8.87 percentage points. Trading ran only four sessions with the Monday holiday. After a modest gain to $505.74 on Tuesday, the stock pushed to a weekly high of $526.79 on Wednesday and finished at $521.10. Thursday brought a 3.36% pullback to $503.60, before a rebound on Friday left the shares at $516.13.
The Week
AMD closed the week at $516.13, up 8.07% from $477.57 the prior Friday. The S&P 500 slipped 0.8% over the same stretch, so AMD outperformed the benchmark by roughly 8.87 percentage points. Trading ran only four sessions with the Monday holiday. After a modest gain to $505.74 on Tuesday, the stock pushed to a weekly high of $526.79 on Wednesday and finished at $521.10. Thursday brought a 3.36% pullback to $503.60, before a rebound on Friday left the shares at $516.13. The shape of the week was an upward move with a midweek dip and recovery. Average daily volume was about 21.3m shares, roughly 15% below the 60-day median, so turnover was not particularly heavy.
Key Events
The week’s company-specific news sat at the intersection of AI and quantum computing. AMD’s partnership with Xanadu stayed in focus, with the Backline project cutting quantum-classical communication latency below 3 microseconds and supporting progress toward fault-tolerant quantum computing. AMD also introduced the ACE and Aria AI Suite, aimed at autonomous systems and enterprise-wide AI integration, while pushing AI security with an emphasis on zero trust, governance, and protection against AI threats. Against a backdrop of rising CPU demand from agentic workloads, AMD expanded further into rack-scale AI.
On 10 September, the broader semiconductor group took a profit-taking hit, with Intel and ARM down around 4% and AMD off 3.16%. Piper Sandler named five chip stocks for the next $2.2t AI compute buildout, and on Friday it said AMD’s biggest growth phase was only beginning. Separately, Ayar Labs expanded its 2026 funding to $650m to scale manufacturing-ready CPO for AI beyond the rack, a supply-side signal the market also worked through.
Analyst Ratings
As of the latest tally, 55 institutions cover AMD: 39 rate it buy, 5 rate it overweight, and 11 rate it hold, with no underweight or sell ratings. The consensus rating is strong buy, and the consensus target of $615.07 sits about 19.17% above the latest close of $516.13. The target range is wide, from $365 to $1,250, so dispersion is meaningful. Among 77 semiconductor companies, AMD ranks second in ratings coverage, well above the industry average of 14 institutions and a median of 9, reflecting how much attention concentrates at the top end of the sector.
The Week Ahead
A batch of US macro data lands next week. On 15 September the New York Fed manufacturing index arrives, with a prior print of 20.6 and a 14.75 forecast. On 16 September retail sales dominate, including retail sales ex-autos (prior -0.3, forecast 0.6), retail control (prior -0.4, forecast 0.4) and headline retail sales (prior -0.6, forecast 0.9), alongside import prices, the NAHB housing index and EIA crude inventories. For a high-multiple growth name like AMD, retail and price data will frame expectations for the rate path ahead and the market’s appetite for growth assets.
In Short
The week’s price gain arrived alongside a cluster of AI-related expectations. Analyst ratings remain tilted positive, but the target spread from $365 to $1,250 shows how much disagreement persists about the pace of AI monetisation. On valuation, the latest P/E of roughly 131x is elevated; the most recent session showed large-lot money on the net-buying side, though that is a single-day snapshot rather than a trend. The real test ahead lies in retail and price data, and whether semis can hold ground after the profit-taking round.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
